Supernus Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Supernus Pharmaceuticals

08/11/2022 23:38

* Supernus Pharmaceuticals Inc  SUPN.OQ  reported quarterly
adjusted earnings of 3 cents​​ per share for the quarter ended
in September. The mean expectation of three analysts for the
quarter was for earnings of 36 cents per share.
    * Revenue rose 19.5% to $177.35 million from a year ago;
analysts
expected $172.48 million. 
    * Supernus Pharmaceuticals Inc's reported EPS for the
quarter was
3 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Supernus Pharmaceuticals Inc shares had risen by 2.6% this
quarter and gained 19.1% so far this year.
    * The company reported quarterly net income of $1.75
million.
    * Wall Street's median 12-month price target for Supernus
Pharmaceuticals Inc is $38.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.36           0.03           Missed
 Jun. 30 2022      0.29           0.14           Missed
 Mar. 31 2022      0.24           0.43           Beat
 Dec. 31 2021      0.24           0.04           Missed